World Cancer Day 2026: 5 cancers you have likely never heard of

On World Cancer Day, we look beyond the usual narratives to highlight five ultra-rare cancers most people have never heard of ...

Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

April 10, 2026 Target Action Date for RP1 in Advanced MelanomaWOBURN, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering ...

Replimune, Inc.: Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides ...

Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced ...